Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 3 of 19 for:    lyme antibody | Lyme Disease

First Clinical Study of the Safety and Blood Levels of a Human Monoclonal Antibody (2217LS) Against Lyme Disease Bacteria in Healthy People

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04863287
Recruitment Status : Active, not recruiting
First Posted : April 28, 2021
Last Update Posted : November 19, 2021
Sponsor:
Collaborator:
Celerion
Information provided by (Responsible Party):
MassBiologics

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 2022
Estimated Study Completion Date : August 2022